Moderna expands beyond vaccines while Recursion bets on AI-driven drug discovery, each with distinct risks, partnerships, and financial profiles.

Recursion Pharmaceuticals combines artificial intelligence, automation, and biotechnology research across multiple ...

Architecture delivery. The stories were vehicles; the real payload was a way of organizing experience into causal, moral, and ...

Buffer overflow vulnerabilities have driven remote code execution for decades and keep appearing in critical network ...

The loop takes agentic AI a step further, by authorizing a swarm of agents to work continuously in the background, endlessly.

Alongside this rapid progress, an equally ambitious effort has emerged to construct ethical frameworks for intelligent ...

The Council for the Indian School Certificate Examinations (CISCE) has released the ISC Computer Science (Subject Code - 868) for the Year 2027 evaluation cycle. It is designed specifically to make ...

Autonomous AI post-training reached frontier scale for the first time: NVIDIA researchers published a paper showing an AI ...

Everyone is racing to point powerful AI models at drug discovery. A growing camp argues the real prize is the layer beneath the models — the connected biological knowledge they reason over — and that ...

The compiler infers, but does not take instructions. There is no syntax for explicit type declarations yet, and the new type ...

MetLife's CMO, Michael Roberts, is leveraging the World Cup not for mere branding, but to solidify the company's core purpose ...

In the AI value chain, application-layer leaders like Palantir and ServiceNow may win long term as chip/cloud margins ...